Praxis Precision Medicines to Report Fourth Quarter and Full Year 2025 Financial Results on Thursday, February 19, 2026, and Participate in Upcoming Investor Conferences
February 10, 2026 - 03:34
Praxis Precision Medicines, Inc., a leader in central nervous system precision neuroscience, has scheduled the release of its fourth quarter and full year 2025 financial results for Thursday, February 19, 2026. The announcement will be made public prior to the opening of the financial markets that day.
Following the release, the company's management will host a conference call and live webcast to discuss the financial performance and provide a comprehensive corporate update. This event will offer investors and analysts direct insight into the company's recent progress and strategic outlook.
In addition to the earnings report, Praxis has confirmed its participation in several upcoming investor conferences. These engagements are part of the company's ongoing commitment to maintaining transparent communication with the investment community and sharing developments in its pipeline of precision neuroscience therapies. The company focuses on developing treatments for psychiatric and neurological disorders by targeting genetic drivers of brain disease.
MORE NEWS
February 9, 2026 - 05:04
Best moves for your portfolio: Buy Ulta Beauty, avoid AristaA recent market analysis highlighted a clear divergence in stock recommendations, with a prominent portfolio manager advocating for shares of Ulta Beauty while advising caution on Arista Networks....
February 8, 2026 - 05:32
Cincinnati Financial (CINF) Q4 Earnings Report Preview: What To Look ForInvestors are turning their attention to Cincinnati Financial Corporation as the property and casualty insurer prepares to release its fourth-quarter financial results after the closing bell on...
February 7, 2026 - 20:21
Ottawa gives Canada Post a $1.01-billion loan amid ongoing financial strugglesThe Government of Canada is providing a major financial infusion to Canada Post, offering a repayable loan of $1.01 billion to address the Crown corporation`s ongoing fiscal challenges. Officials...
February 7, 2026 - 07:59
A Look At CleanSpark (CLSK) Valuation After Recent Share Price VolatilityCleanSpark (CLSK) has become a focal point for market observers following a dramatic single-day surge of nearly 22%, a move that starkly contrasts with its negative performance over recent weeks...